On October 20, 2020, Panacea Acquisition Corp. (“Panacea”), and Panacea Merger Subsidiary Corp. (“Merger Sub”), a direct, wholly owned subsidiary of Panacea, entered into an Agreement and Plan of Merger (as it may be amended from time to time, the...Agreement and Plan of Merger • August 9th, 2021
Contract Type FiledAugust 9th, 2021The following questions and answers highlight selected information from this proxy statement/prospectus and briefly address certain questions that you may have regarding the merger and the Panacea Special Meeting. We urge you to read carefully the remainder of this proxy statement/prospectus because the information in this section may not provide all the information that might be important to you in determining how to vote. Additional important information is also contained in the financial statements and annexes attached hereto and other documents referred to herein.